Severe visceral obesity, fatty liver and diabetes after orchiectomy for prostate cancer

Nobuo Kajitani, Junko Takahashi, Hiroyuki Honda, Jun Hamahara, Shinichiro Ando

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

A 79-year-old man without a history of diabetes underwent orchiectomy for prostate cancer. Eight months after the operation, he suffered severe deterioration of visceral fat deposition, fatty liver and diabetes. Treatment for diabetes with canagliflozin and dulaglutide resulted in improvement in his glycemic control, visceral fat and fatty liver. Visceral fat-dominant deposition, which differs from the typical course after androgen deprivation therapy, may have been associated with severe exacerbation of diabetes and fatty liver. Glycemic management with a sodium glucose cotransporter 2 (SGLT2) inhibitor and glucagon-like peptide (GLP)-1 receptor agonist may help improve the glucose metabolism, visceral fat deposition and fatty liver after orchiectomy.

Original languageEnglish
Pages (from-to)2281-2285
Number of pages5
JournalInternal Medicine
Volume59
Issue number18
DOIs
Publication statusPublished - Jun 2020

Keywords

  • Diabetes mellitus
  • Fatty liver
  • GLP-1 receptor agonist
  • Orchiectomy
  • SGLT2 inhibitor
  • Visceral fat

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Severe visceral obesity, fatty liver and diabetes after orchiectomy for prostate cancer'. Together they form a unique fingerprint.

Cite this